Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway

Planta Medica

Volumn 79, Issue 2, 2013, Pages 102-109

  Zeng, Zhaojing ^a   Zhan, Lingling ^a   Liao, Hui ^a   Chen, Lan ^a   Lv, Xiaoping ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

2,4,6 trinitrobenzene sulfonic acid; Curcuma longa; curcumin; interleukin 27; NF B; sulfasalazine; TLR4; Zingiberaceae

Indexed keywords

CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 27; MESSENGER RNA; MYELOPEROXIDASE; SALAZOSULFAPYRIDINE; SULFONIC ACID DERIVATIVE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COLITIS; COLON; CURCUMIN; DISEASE MODELS, ANIMAL; GASTROINTESTINAL AGENTS; INFLAMMATION; INTERLEUKINS; INTESTINAL MUCOSA; MALE; NF-KAPPA B; PEROXIDASE; RANDOM ALLOCATION; RATS; SIGNAL TRANSDUCTION; SULFASALAZINE; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TRINITROBENZENESULFONIC ACID;

CURCUMA LONGA; RATTUS; ZINGIBERACEAE;

EID: 84873055253     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0032-1328057     Document Type: Article

References (45)

1. Molodecky N. A., Soon I. S., Rabi D. M., Ghali W. A., Ferris M., Chernoff G., Benchimol E. I., Panaccione R., Ghosh S., Barkema H. W., Kaplan G. G. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology: 2012; 142 46 54, e42
2. Gismera C. S., Aladren B. S. Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing? World J Gastroenterol: 2008; 14 5491 5498
3. Schreiber S., Raedler A., Stenson W. F., MacDermott R. P. The role of the mucosal immune system in inflammatory bowel disease. Gastroenterol Clin North Am: 1992; 21 451 502
4. Li M. C., He S. H. IL-10 and its related cytokines for treatment of inflammatory bowel disease. World J Gastroenterol: 2004; 10 620 625
5. Liu Y., Zhang Z., Wang L., Li J., Dong L., Yue W., Chen J., Sun X., Zhong L., Sun D. TLR4 monoclonal antibody blockade suppresses dextran-sulfate-sodium- induced colitis in mice. J Gastroenterol Hepatol: 2010; 25 209 214
6. Nielsen O. H., Kirman I., Rudiger N., Hendel J., Vainer B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol: 2003; 38 180 185 (Pubitemid 36349930)
7. Liu J., Guan X., Ma X. Regulation of IL-27p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways. J Exp Med: 2007; 204 141 152 (Pubitemid 46148764)
8. Duerr R. H., Taylor K. D., Brant S. R., Rioux J. D., Silverberg M. S., Daly M. J., Steinhart A. H., Abraham C., Regueiro M., Griffiths A., Dassopoulos T., Bitton A., Yang H., Targan S., Datta L. W., Kistner E. O., Schumm L. P., Lee A. T., Gregersen P. K., Barmada M. M., Rotter J. I., Nicolae D. L., Cho J. H. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science: 2006; 314 1461 1463 (Pubitemid 44871953)
9. Schmidt C., Giese T., Ludwig B., Mueller-Molaian I., Marth T., Zeuzem S., Meuer S. C., Stallmach A. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohns disease but not in ulcerative colitis. Inflamm Bowel Dis: 2005; 11 16 23 (Pubitemid 40340252)
10. Deguchi Y., Andoh A., Inatomi O., Yagi Y., Bamba S., Araki Y., Hata K., Tsujikawa T., Fujiyama Y. Curcumin prevents the development of dextran sulfate Sodium (DSS)-induced experimental colitis. Dig Dis Sci: 2007; 52 2993 2998 (Pubitemid 47512496)
11. Xia J., Deng C., Zhang M., Zun Z., Kiang H. Effects of curcumin on NF-κB and TNF-α expression in the intestinal mucosa of mice with dextran-sulfate-sodium-induced ulcerative colitis. World Chin J Digestol: 2005; 13 255 257
12. Kumar A., Dhawan S., Hardegen N. J., Aggarwal B. B. Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. Biochem Pharmacol: 1998; 55 775 783 (Pubitemid 28319640)
13. Morris G. P., Beck P. L., Herridge M. S., Depew W. T., Szewczuk M. R., Wallace J. L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology: 1989; 96 795 803 (Pubitemid 19057602)
14. Luk H. H., Ko J. K., Fung H. S., Cho C. H. Delineation of the protective action of zinc sulfate on ulcerative colitis in rats. Eur J Pharmacol: 2002; 443 197 204 (Pubitemid 34603615)
15. Klebanoff S. J., Coombs R. W. Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of the myeloperoxidase system. J Clin Invest: 1992; 89 2014 2017
16. Song W., Zhang Z., Xiao B. Effects of curcumin on MPO and SOD of methotrexate-induced small intestinal damage in rats. Mod Digest Interv: 2008; 13 14 17
17. Chadwick V. S., Schlup M. M., Ferry D. M., Chang A. R., Butt T. J. Measurements of unsaturated vitamin B12-binding capacity and myeloperoxidase as indices of severity of acute inflammation in serial colonoscopy biopsy specimens from patients with inflammatory bowel disease. Scand J Gastroenterol: 1990; 25 1196 1204
18. Poltorak A., Smirnova I., He X., Liu M. Y., Van Huffel C., McNally O., Birdwell D., Alejos E., Silva M., Du X., Thompson P., Chan E. K., Ledesma J., Roe B., Clifton S., Vogel S. N., Beutler B. Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis: 1998; 24 340 355 (Pubitemid 28524834)
19. Liu Y., Wang L., Zhang Z. Protective effects of toll like receptor 4 monoclonal antibodies on gut mucosal nuclear factor kappa B signaling pathway in mice with dextran-sulfate-sodium-induced acute ulcerative colitis. Shanghai Med J: 2009; 32 702 705
20. Lubbad A., Oriowo M. A., Khan I. Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis. Mol Cell Biochem: 2009; 322 127 135
21. Siddique I., Khan I. Mechanism of regulation of Na-H exchanger in inflammatory bowel disease: role of TLR-4 signaling mechanism. Dig Dis Sci: 2011; 56 1656 1662
22. Schmid R. M., Adler G. NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases. Gastroenterology: 2000; 118 1208 1228
23. Gan H., Ouyang Q., Jia D., Xia Q. [Activation of nuclear factor-kappaB and its relationship with cytokine gene expression in colonic mucosa of ulcerative colitis patients]. Zhonghua Nei Ke Za Zhi: 2002; 41 252 255
24. Blackwell T. S., Christman J. W. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol: 1997; 17 3 9 (Pubitemid 127500814)
25. Neurath M. F., Fuss I., Schurmann G., Pettersson S., Arnold K., Muller-Lobeck H., Strober W., Herfarth C., Buschenfelde K. H. Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann N Y Acad Sci: 1998; 859 149 159 (Pubitemid 29021014)
26. Moynagh P. N. The NF-kappaB pathway. J Cell Sci: 2005; 118 4589 4592
27. Li J. H., Yu J. P., Yu H. G., Xu X. M., Yu L. L., Liu J., Luo H. S. Melatonin reduces inflammatory injury through inhibiting NF-kappaB activation in rats with colitis. Mediators Inflamm: 2005; 2005 185 193 (Pubitemid 41381508)
28. Xia B., Crusius J., Meuwissen S., Pena A. Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies. World J Gastroenterol: 1998; 4 446 458 (Pubitemid 128620212)
29. Pflanz S., Timans J. C., Cheung J., Rosales R., Kanzler H., Gilbert J., Hibbert L., Churakova T., Travis M., Vaisberg E., Blumenschein W. M., Mattson J. D., Wagner J. L., To W., Zurawski S., McClanahan T. K., Gorman D. M., Bazan J. F., de Waal Malefyt R., Rennick D., Kastelein R. A. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity: 2002; 16 779 790 (Pubitemid 34786477)
30. Yoshida H. [Immune regulation by IL-27 for therapeutic usage]. Nihon Rinsho Meneki Gakkai Kaishi: 2009; 32 202 213
31. Yoshimura T., Takeda A., Hamano S., Miyazaki Y., Kinjyo I., Ishibashi T., Yoshimura A., Yoshida H. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol: 2006; 177 5377 5385 (Pubitemid 44527610)
32. Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T. W., Yoshimura A., Yoshida H. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol: 2003; 170 4886 4890 (Pubitemid 36554716)
33. Owaki T., Asakawa M., Fukai F., Mizuguchi J., Yoshimoto T. IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways. J Immunol: 2006; 177 7579 7587 (Pubitemid 44846272)
34. Castoldi A., Braga T. T., Correa-Costa M., Aguiar C. F., Bassi E. J., Correa-Silva R., Elias R. M., Salvador F., Moraes-Vieira P. M., Cenedeze M. A., Reis M. A., Hiyane M. I., Pacheco-Silva A., Goncalves G. M., Saraiva Camara N. O. TLR2, TLR4 and the MYD88 signaling pathway are crucial for neutrophil migration in acute kidney injury induced by sepsis. PLoS One: 2012; 7 e37584
35. Stumhofer J. S., Laurence A., Wilson E. H., Huang E., Tato C. M., Johnson L. M., Villarino A. V., Huang Q., Yoshimura A., Sehy D., Saris C. J., OShea J. J., Hennighausen L., Ernst M., Hunter C. A. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol: 2006; 7 937 945 (Pubitemid 44263907)
36. Sasaoka T., Ito M., Yamashita J., Nakajima K., Tanaka I., Narita M., Hara Y., Hada K., Takahashi M., Ohno Y., Matsuo T., Kaneshiro Y., Tanaka H., Kaneko K. Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells. Am J Physiol Gastrointest Liver Physiol: 2011; 300 G568 G576
37. Cui Y., Liu Z., Zhao Z. Significance of IL-27 expression in the intestinal mucosa of patients with inflammatory bowel disease. World Chin J Digestol: 2010; 18 39 43
38. Wirtz S., Becker C., Fantini M. C., Nieuwenhuis E. E., Tubbe I., Galle P. R., Schild H. J., Birkenbach M., Blumberg R. S., Neurath M. F. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation. J Immunol: 2005; 174 2814 2824 (Pubitemid 40279698)
39. Sugimoto K., Hanai H., Tozawa K., Aoshi T., Uchijima M., Nagata T., Koide Y. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology: 2002; 123 1912 1922 (Pubitemid 35408315)
40. Jobin C., Bradham C. A., Russo M. P., Juma B., Narula A. S., Brenner D. A., Sartor R. B. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol: 1999; 163 3474 3483 (Pubitemid 29431852)
41. Rao C. V., Kawamori T., Hamid R., Reddy B. S. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis: 1999; 20 641 644 (Pubitemid 29151301)
42. Chen A., Xu J., Johnson A. C. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene: 2006; 25 278 287 (Pubitemid 43083689)
43. Lee Y. K., Park S. Y., Kim Y. M., Park O. J. Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. Ann N Y Acad Sci: 2009; 1171 489 494
44. Prasad C. P., Rath G., Mathur S., Bhatnagar D., Ralhan R. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling. Chem Biol Interact: 2009; 181 263 271
45. Ak T., Gulcin I. Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact: 2008; 174 27 37